ClinConnect ClinConnect Logo
Search / Trial NCT03812276

Neodent Implantable Devices of GM Line

Launched by NEODENT · Jan 22, 2019

Trial Information

Current as of August 11, 2025

Completed

Keywords

Dental Implants

ClinConnect Summary

The study protocol was reviewed and approved by an Ethics Committee (CE) in Brazil.

The sample will be prospectively and consecutively selected and will consist of patients who are 18 years of age or older, who are in need of one or more dental implants and who qualify for placement of Neodent GM Helix implants. Informed consent in writing will be obtained from each patient participating in the study prior to any study related procedure.

Neodent Acqua GM Helix implants will be placed under local anesthesia and with adequate bone bed preparation, as recommended by the manufacturer. Multipl...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age or older;
  • Need of one or more dental implants;
  • Qualify for placement of Neodent GM Helix implants.
  • Exclusion Criteria:
  • As exclusion criteria, solely the device contraindications according to the IFU (instructions for use) will be applied:
  • Signs of allergy or hypersensitivity to the chemical ingredients of the material: titanium alloy;
  • Presence of acute inflammatory or infectious processes in live tissue;
  • Unsuitable bone volume or quality;
  • Serious medical problems (e.g. bone metabolism disorders, blood clotting disorders, unsuitable healing capacity);
  • Insufficient oral hygiene;
  • Incomplete jawbone growth;
  • Patient uncooperative and not motivated;
  • Abuse of drugs or alcohol;
  • Psychosis;
  • Prolonged functional disorders which resist any treatment with medications;
  • Xerostomia;
  • Weakened immunological system;
  • Diseases which require the use of steroids;
  • Uncontrolled endocrinological diseases;
  • Pregnancy.

About Neodent

Neodent, a leading global provider of dental implants and solutions, specializes in innovative technologies and products that enhance dental restoration and rehabilitation. With a commitment to advancing oral healthcare, Neodent invests in research and development, ensuring that its clinical trials adhere to the highest standards of safety and efficacy. The company collaborates with dental professionals and institutions worldwide to explore new methodologies and improve patient outcomes, positioning itself at the forefront of dental innovation and excellence.

Locations

Curitiba, Paraná, Brazil

Curitiba, Paraná, Brazil

Curitiba, , Brazil

Curitiba, , Brazil

Patients applied

0 patients applied

Trial Officials

Larissa Trojan, PhD

Study Chair

Neodent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials